搜索临床试验以:Dimebon 20 毫克口服 TID
总计1150个结果
-
PfizerMedivation, Inc.终止
-
Priovant Therapeutics, Inc.尚未招聘葡萄膜炎 | 葡萄膜炎,后部 | 葡萄膜炎,中间
-
McGill University Health Centre/Research Institute...Pulmonem Inc.招聘中
-
Beijing Administration of Traditional Chinese Medicine...Beijing Hospital of Traditional Chinese Medicine完全的
-
Sichuan Provincial People's Hospital未知
-
Alexion Pharmaceuticals终止
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AG主动,不招人
-
GlaxoSmithKline完全的
-
gicare Pharma Inc.Algorithme Pharma Inc完全的
-
Merck Sharp & Dohme LLC终止DLBCL | AML,包括新发 AML 和继发于 MDS 的 AML
-
LG Life Sciences完全的
-
Jadran Galenski laboratorij d.d.完全的
-
Shaheed Zulfiqar Ali Bhutto Medical University完全的
-
Medicines for Malaria VentureNucleus Network Ltd; Southern Star Research Pty Ltd.完全的
-
Memorial Sloan Kettering Cancer CenterSanofi; Weill Medical College of Cornell University; Thomas Jefferson University完全的
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of Munich主动,不招人
-
Institute of Hematology & Blood Diseases Hospital尚未招聘鲁索替尼对 AA HSCT 受者的 aGVHD 的预防价值
-
Suzhou Kintor Pharmaceutical Inc,Suzhou Koshine Biomedica, Inc.主动,不招人